Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 21 Show results per page	View Search Criteria \| Help With Results

Last Modified: 7/20/2007


1.		Phase III Randomized Study of Radiotherapy with vs without BUDR and Followed by PCV (PCB/CCNU/VCR) for Anaplastic Astrocytomas

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				NCI				RTOG-9404 NCCTG-947251, SWOG-9340, RTOG-94-04

Last Modified: 5/18/2006


2.		Phase III Randomized Comparison of Conventional Fractionated Radiotherapy with vs without BUdR in Patients with Tumors Metastatic to the Brain

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				15 and over				NCI				NCOG-6G852 NCI-T86-0222D, T86-0222

Last Modified: 5/5/2006


3.		Phase III Randomized Comparison of Conventional-Fractionation Radiotherapy with vs without Radiosensitization with 5-Bromodeoxyuridine in Patients with Solid Tumors Metastatic to the Brain

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				15 and over				NCI				RTOG-8905 RTOG-89-05

Last Modified: 11/8/2007


4.		Phase I/II Radiotherapy with BUdR Sensitization followed by Chemotherapy with PCV (PCB/CCNU/VCR) for Primary Malignant Brain Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				15 and over								NCI-D82-004-688 BTRC-8222

Last Modified: 12/1/1992


5.		Phase I/II Radiosensitization with Intra-Arterial BUDR plus Cranial Radiotherapy in Patients with Malignant Gliomas (Summary Last Modified 12/92)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				16 and over				NCI				MICH-T87-0015 NCI-T87-0015O, T87-0015

Last Modified: 4/1/2000


6.		Phase II Study of Accelerated Fractionation Radiotherapy with Infusional BUDR Followed by PCV (PCB/CCNU/VCR) in Patients with Supratentorial Glioblastoma Multiforme and Gliosarcoma (Summary Last Modified 04/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				over 15				NCI				MDA-DM-93088 NCI-T93-0118D, T93-0118

Last Modified: 8/1/1999


7.		Phase II Study of Accelerated Concomitant Boost Radiotherapy in Transitional Cell Carcinoma of the Bladder (TCCB) (Summary Last Modified 08/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				MCC-RAD-9305 NCI-T96-0071, T96-0071

Last Modified: 2/1/2001 First Published: 9/1/1998


8.		Phase II Study of High Dose Cytarabine, Mitoxantrone, and Amifostine Followed by Consolidation with Cytarabine and Idarubicin, and Maintenance with Isotretinoin and Interferon Alfa in Previously Untreated Patients with Standard Risk Acute Myelogenous Leukemia and Its Variants (Summary Last Modified 02/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				70 and under				NCI, Pharmaceutical / Industry				RUSH-AML-9754 ALZA-RUSH-AML-9754, NCI-V98-1445, NCT00003405

Last Modified: 9/1/2002 First Published: 5/1/1999


9.		Phase II Study of Broxuridine in Patients With Stage I or II Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Diagnostic, Treatment				Completed				Not specified				NCI				UCHSC-98374 NCI-T98-0058, NCT00003832, T98-0058

Last Modified: 11/7/2007


10.		Phase II External Beam Radiotherapy plus BUdR Followed by PCV (PCB/CCNU/VCR) for Primary Malignant Brain Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				over 15								NCOG-6G821 NCOG-6G-82-1

Select All on One Page


					1 2 3 Next >

| | | | | | | |

A Service of the National Cancer Institute